Pruski Maciej J, Blachut Aleksandra M, Konkolewska Magda, Janas Adam, Hrycek Eugeniusz, Buszman Piotr P, Kiesz Radoslaw S
1 Center for Cardiovascular Research and Development, American Heart of Poland S.A., Katowice, Poland.
2 San Antonio Endovascular and Heart Institute, San Antonio, TX, USA.
Vasc Endovascular Surg. 2017 Feb;51(2):67-71. doi: 10.1177/1538574416689424. Epub 2017 Jan 19.
This was the first prospective study to assess the safety and efficiency of MynxGrip vascular closure device (VCD) in peripheral interventions with antegrade access.
We enrolled 66 consecutive patients from 1 center. All patients were discharged home on the day of procedure and were observed for adverse events at 1 and 30 days of follow-up. No major complications were observed. The rate of minor complications (conversion to manual or mechanical compression) was 7.6%. Postdischarge, 3% of patients experienced minor complications-small abscess, ipsilateral deep vein thrombosis. In 1 patient, a second VCD was deployed after device failure. The derived device failure rate was 5.9%. No patients required hospitalization. No late bleeding and no hematomas >6 cm were noted. The mean time to discharge was 4 hours and 5 minutes.
The MynxGrip was safe and effective in sealing access sites after antegrade femoral artery puncture with same-day discharge.
这是第一项评估MynxGrip血管闭合装置（VCD）在顺行入路外周介入治疗中的安全性和有效性的前瞻性研究。
我们从1个中心连续纳入了66例患者。所有患者在手术当天出院，并在随访1天和30天时观察不良事件。未观察到重大并发症。轻微并发症（转为手动或机械压迫）发生率为7.6%。出院后，3%的患者出现轻微并发症——小脓肿、同侧深静脉血栓形成。1例患者在装置故障后使用了第二个VCD。得出的装置故障率为5.9%。无患者需要住院治疗。未观察到迟发性出血，也未发现血肿>6 cm。平均出院时间为4小时5分钟。
MynxGrip在经股动脉顺行穿刺后封闭穿刺部位方面安全有效，且患者可当日出院。
